tiprankstipranks
RHON-KLINIKUM AG (DE:RHK)
XETRA:RHK
Holding DE:RHK?
Track your performance easily

RHON-KLINIKUM AG (RHK) Technical Analysis

0 Followers

Summary of all the Indicators

Overall Consensus
Strong Buy
16Bullish
5Neutral
0Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
0Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
RHON-KLINIKUM AG’s (RHK) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting RHON-KLINIKUM AG is a Buy.
RHON-KLINIKUM AG’s (RHK) 20-Day exponential moving average is 12.54, while RHON-KLINIKUM AG’s (RHK) share price is €12.6, making it a Buy.
RHON-KLINIKUM AG’s (RHK) 50-Day exponential moving average is 12.44, while RHON-KLINIKUM AG’s (RHK) share price is €12.6, making it a Buy.

RHON-KLINIKUM AG (RHK) Pivot Points

Nov 24, 2024, 02:27 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
11.77
11.93
12.27
12.43
12.77
12.93
13.27
Fibonacci
11.93
12.12
12.24
12.43
12.62
12.74
12.93
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

RHON-KLINIKUM AG (RHK) Moving Averages

Nov 24, 2024, 02:27 AM
Period
Simple
Exponential
MA5
12.50Buy
12.53Buy
MA10
12.48Buy
12.52Buy
MA20
12.60Buy
12.54Buy
MA50
12.45Buy
12.44Buy
MA100
12.17Buy
12.25Buy
MA200
11.94Buy
11.83Buy
RHON-KLINIKUM AG’s (RHK) 10-Day exponential moving average is 12.52, while RHON-KLINIKUM AG’s (RHK) share price is €12.6, making it a Buy.
RHON-KLINIKUM AG’s (RHK) 100-Day exponential moving average is 12.25, while RHON-KLINIKUM AG’s (RHK) share price is €12.6, making it a Buy.
RHON-KLINIKUM AG’s (RHK) stock price is €12.6 and RHON-KLINIKUM AG’s (RHK) 50-day simple moving average is 12.45, creating a Buy signal.
RHON-KLINIKUM AG’s (RHK) stock price is €12.6 and RHON-KLINIKUM AG’s (RHK) 100-day simple moving average is 12.17, creating a Buy signal.
RHON-KLINIKUM AG’s (RHK) stock price is €12.6 and RHON-KLINIKUM AG’s (RHK) 200-day simple moving average is 11.94, creating a Buy signal.

RHON-KLINIKUM AG (RHK) Technical Indicators

Nov 24, 2024, 02:27 AM
Name
Value
Implied Action
RSI (14)
51.82
Neutral
STOCH (9,6)
78.57
Neutral
STOCHRSI (14)
66.67
Neutral
MACD (12,26)
>-0.01
Buy
ADX (14)
16.85
Buy
Williams %R
-33.33
Buy
CCI (14)
7.69
Neutral
ATR (14)
0.20
-
Ultimate Oscillator
64.01
Neutral
ROC
0.00
-
RHON-KLINIKUM AG’s (RHK) Relative Strength Index (RSI) is 51.82, creating a Neutral signal.
RHON-KLINIKUM AG’s (RHK) Trend Strength Indicator (ADX) is 16.85, creating a Buy signal.
RHON-KLINIKUM AG’s (RHK) Commodity Channel Index (CCI) is 7.69, creating a Neutral signal.

FAQ

Is RHK a Buy, Hold, or Sell?
Based on RHK’s technical indicators, RHK is a Strong Buy.
    What is RHK’s RSI (14)?
    RHK’s RSI (14) is 51.82, which suggests RHK is a Neutral.
      What is RHK’s MACD?
      RHK’s MACD is >-0.01, which suggests RHK is a Buy.
        What is RHK’s 5-day moving average?
        RHK’s 5-day moving average is 12.50, which suggests RHK is a Buy.
          What is RHK’s 20-day moving average?
          RHK 20-day moving average is 12.60, which suggests RHK is a Buy.
            What is RHK’s 50-day moving average?
            RHK’s 50-day moving average is 12.45, which suggests RHK is a Buy.
              What is RHK’s 200-day moving average?
              RHK’s 200-day moving average is 11.94, which suggests RHK is a Buy.
                What is RHK’s Williams % R (14)?
                RHK’s Williams % R (14) is -33.33, which suggests RHK is a Buy.
                  What is RHK’s CCI (14)?
                  RHK’s CCI (14) is 7.69, which suggests RHK is a Neutral.
                    What is the share price of RHON-KLINIKUM AG?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis